Director, Medical Affairs
Illumina$180,000 - $220,000/year
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
Not SpecifiedCompensation
Junior (1 to 2 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, GeneticsIndustries
Requirements
The ideal candidate should possess a Ph.D. in Molecular Biology, Genetics, Pharmacology, or a related field, along with at least two years of industry experience. Familiarity with perturb-seq and single-cell genomics is required, as is the ability to troubleshoot technical issues, adapt to new protocols, and optimize methodologies for performing large-scale pooled screens. Excellent written and verbal communication skills, including a track record of presenting complex scientific results, are also necessary, alongside demonstrated success in collaborative, team-oriented environments.
Responsibilities
This role involves developing, implementing, and scaling high-throughput CRISPR-based screening protocols to uncover genotype-phenotype relationships at scale, driving continuous innovation in experimental workflows and screening methodologies, partnering with computational biology, AI/ML, and drug discovery teams to analyze and interpret functional genomics datasets, identifying and resolving challenges in data generation, independently managing multiple projects to ensure timely delivery of high-quality data, and maintaining accurate records of experiments and contributing to scientific presentations.
Skills
CRISPR
perturb-seq
single-cell genomics
troubleshooting
protocol optimization
data analysis
scientific communication
collaboration
Abata Therapeutics
Develops therapies for autoimmune diseases
About Abata Therapeutics
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.
Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees